GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,978,000 | -19.8% | 20,319 | +1.1% | 0.05% | -25.4% |
| Q2 2020 | $2,466,000 | +54.6% | 20,093 | +10.3% | 0.07% | +14.5% |
| Q1 2020 | $1,595,000 | -15.2% | 18,211 | +1.2% | 0.06% | +100.0% |
| Q4 2019 | $1,882,000 | +36.4% | 18,000 | +50.0% | 0.03% | +10.7% |
| Q3 2019 | $1,380,000 | -33.3% | 12,000 | 0.0% | 0.03% | -49.1% |
| Q2 2019 | $2,069,000 | -38.6% | 12,000 | -40.0% | 0.06% | -34.5% |
| Q1 2019 | $3,371,000 | +44.2% | 20,000 | -16.7% | 0.08% | -13.4% |
| Q4 2018 | $2,337,000 | +8.2% | 24,000 | +92.0% | 0.10% | +70.2% |
| Q3 2018 | $2,159,000 | -12.7% | 12,500 | -29.5% | 0.06% | -3.4% |
| Q2 2018 | $2,474,000 | +9.8% | 17,733 | -11.3% | 0.06% | -16.9% |
| Q1 2018 | $2,253,000 | – | 20,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |